U.S. markets closed

Enlivex Therapeutics Ltd. (ENLV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.49+0.20 (+1.94%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
Total Revenue
0
0
0
-
Operating Expense
8,927
8,619
5,299
5,955
Operating Income
-8,927
-8,619
-5,299
-5,955
Net Non Operating Interest Income Expense
1,096
231
135
34
Other Income Expense
-
-996
922
4
Pretax Income
-8,827
-9,384
-4,242
-5,917
Tax Provision
-
-
-
28
Net Income Common Stockholders
-9,025
-9,582
-4,901
-5,945
Diluted NI Available to Com Stockholders
-9,025
-9,582
-4,901
-5,945
Basic EPS
-
-0.0089
-0.0112
-0.0143
Diluted EPS
-
-0.0089
-0.0112
-0.0143
Basic Average Shares
-
1,081
438.668
414.204
Diluted Average Shares
-
1,081
438.668
414.204
Total Operating Income as Reported
-8,927
-8,619
-5,299
-5,955
Total Expenses
8,927
8,619
5,299
5,955
Net Income from Continuing & Discontinued Operation
-8,827
-9,384
-4,242
-5,945
Normalized Income
-8,827
-8,388
-5,164
-5,948
Interest Income
284
238
138
39
Net Interest Income
1,096
231
135
34
EBIT
-8,881
-8,619
-5,299
-5,955
EBITDA
-8,633
-
-
-
Reconciled Depreciation
248
206
121
64
Net Income from Continuing Operation Net Minority Interest
-8,827
-9,384
-4,242
-5,945
Total Unusual Items Excluding Goodwill
-
-996
922
4
Total Unusual Items
-
-996
922
4
Normalized EBITDA
-8,633
-7,417
-6,100
-5,895
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0.96